Replies to post #245474 on Biotech Values

[DewDiligence]

TSVT sells all_assets_other_than Abecma to REGN for $5M(!?) plus an undisclosed contingent payment:

https://finance.yahoo.com/news/1-2seventy-bio-sell-experimental-123259198.html

TSVT is the 2021 oncology spinoff from BLUE (#msg-166641248). BMY is TVST’s partner for the development and commercialization of Abecma.